US ex rel Campie v. Gilead Sciences, Inc.
US ex rel Campie v. Gilead Sciences, Inc., 15-16380
Reversing the district court’s dismissal of claims under the False Claims Act by realtors against their former employer who made false statements about its compliance with FDA regulations regarding certain HIV drugs resulting in the receipt of billions of dollars from the federal government and alleging retaliation against the complaining realtor, holding that the realtors adequately pled a claim for retaliation.
- Published 2017/07/07
- United States Ninth Circuit